Does an Asymptomatic Uterine Polyp Need to Be Removed?
At a Glance
An asymptomatic endometrial polyp does not always need immediate removal. Observation with planned ultrasound follow-up may be reasonable, especially before menopause and for small polyps, while postmenopause, larger size, bleeding, or cancer risk factors may favor hysteroscopic removal.
In this answer
4 sections
If you have been diagnosed with an asymptomatic endometrial (uterine) polyp—meaning you have no abnormal bleeding, spotting, or pelvic pain—you do not automatically need surgery [1]. The decision to remove a symptom-free polyp is highly individualized. Often, a “watch and wait” approach (called expectant management) is a safe and reasonable option for select patients when accompanied by a planned follow-up [2]. However, depending on your menopausal status, the polyp’s size, and your personal medical history, your doctor might recommend a hysteroscopic polypectomy—a targeted procedure to remove the polyp and test its tissue [1].
An endometrial polyp is a growth from the inner lining of the uterus. The vast majority of these polyps are benign (non-cancerous). However, a small percentage can contain premalignant (precancerous) or malignant (cancerous) cells. In a large meta-analysis of women who had polyps surgically removed, cancerous cells were found in about 1.89% of women with no symptoms, compared to 5.14% of women who experienced symptoms like abnormal bleeding [3]. It is important to know that these numbers come from studies of women who already underwent surgery, so they do not predict your exact individual risk, but they do show that being symptom-free lowers the risk considerably [3].
Menopausal Status Matters
Your age and whether you have gone through menopause are major factors in your care plan.
- Premenopausal patients: If you are still having regular menstrual periods, polyps have a higher chance of shrinking or disappearing on their own (spontaneous regression). Studies show regression occurs most frequently in younger women and with polyps smaller than 1 centimeter (10 mm) [4][5][6]. Unless you have specific risk factors for uterine cancer, observation is often a common and reasonable choice [1][2].
- Postmenopausal patients: After menopause, the baseline risk of finding abnormal cells inside a polyp increases. The risk of malignancy in excised polyps is around 4.93% for postmenopausal women, compared to 1.12% for premenopausal women [3]. According to the 2021 guidelines from the American Association of Gynecologic Laparoscopists (AAGL), removal is generally considered for postmenopausal patients if the polyp is larger than 2 centimeters (20 mm) or if other cancer risk factors exist [1]. For polyps smaller than 2 cm in postmenopausal women without risk factors, removal has not been shown to improve survival rates or cost-effectiveness, making individualized observation a viable option to discuss [1][2].
Key Factors That Influence the Decision
Even if you feel completely fine, your doctor will evaluate the big picture of your health.
Polyp Size and Appearance
Larger polyps are less likely to resolve on their own and may carry a slightly higher risk of containing abnormal cells. While size alone is not a perfect predictor of cancer [7], some studies have found rising rates of precancerous cells as polyps grow larger [8]. If an ultrasound shows unusual blood flow (vascularity) or a concerning shape, your doctor will likely recommend removal [9][10]. Note that a regular ultrasound can suggest a polyp is present, but it cannot definitively confirm whether it is benign; sometimes a saline ultrasound or direct camera inspection (hysteroscopy) is needed for a clearer view [11][1].
Hidden Risk Factors
Certain health conditions increase your overall risk for endometrial cancer. If you have these conditions, clinical guidelines suggest having a lower threshold for removing an asymptomatic polyp [1][2]:
- Metabolic conditions: Obesity, Type 2 diabetes, and high blood pressure (hypertension) are linked to a higher chance of finding premalignant cells in polyps [7][12].
- Hormonal factors: Prolonged exposure to estrogen, polycystic ovary syndrome (PCOS), or a genetic history like Lynch syndrome can elevate your overall uterine cancer risk, influencing the decision to remove a polyp [7][13].
- Tamoxifen use: If you take tamoxifen for breast cancer, your risk of developing polyps and other uterine abnormalities is altered [14][15]. While evidence on the exact cancer risk of polyps in tamoxifen users is mixed, any known polyp warrants a careful discussion about removal with your care team [16][7].
Are You Truly Asymptomatic?
Sometimes, a patient might forget about a brief episode of spotting.
- If you are postmenopausal: Any spotting or bleeding after menopause is not normal and requires prompt medical evaluation [1]. Bleeding increases the risk of malignancy and usually means the polyp should be evaluated and removed [3].
- If you are premenopausal: Occasional spotting might have other causes, but it should still be discussed with your doctor to see if it changes your polyp treatment plan [1].
Future Fertility Goals
If you are actively trying to conceive, the presence of a polyp might affect an embryo’s ability to implant in the uterus, though the evidence is mixed [1]. Routine removal for all subfertile patients (those struggling to conceive) is not universally supported by guidelines [1]. However, removing a polyp before Intrauterine Insemination (IUI) may improve pregnancy rates [17]. For In Vitro Fertilization (IVF), the benefits of removal are less clear, though it is sometimes considered after repeated IVF failures [18][19].
What Does Observation Involve?
If you and your doctor choose observation, you need a concrete follow-up plan. This usually involves scheduling a repeat transvaginal ultrasound in several months to see if the polyp has grown, stayed the same, or shrunk [4][20]. You should also be instructed on when to call your doctor. Contact your clinic promptly if you develop any new postmenopausal bleeding, new or persistent heavy menstrual bleeding, or unusual pelvic pain.
What Does Removal Involve?
If removal is recommended, the standard treatment is hysteroscopic polypectomy [1]. This procedure uses a thin, lighted tube with a camera (a hysteroscope) inserted through the vagina and cervix to see inside the uterus and carefully remove the polyp. It can be performed in an office setting or an operating room, depending on the polyp’s size, your anatomy, and your comfort level [21][22].
While generally safe, it is still a surgical procedure. Potential risks include cramping, bleeding, infection, fluid-related complications, incomplete removal, or, rarely, a small tear in the uterus (perforation) or scar tissue formation (adhesions) [22][23].
The primary benefit of this procedure is pathology. Removing the polyp allows a laboratory to test the tissue under a microscope, which is the best way to accurately diagnose the lesion and rule out cancer within that specific polyp [1]. Guidelines advise that “blind” scraping of the uterus (D&C, or dilation and curettage) should not be used as the primary method for polyp removal because it can easily miss focal abnormalities [1][11]. By using a camera for guided removal, the clinician can ensure the specific polyp is captured for accurate testing.
Common questions in this guide
Can an asymptomatic uterine polyp be left untreated?
Does menopause change whether a uterine polyp should be removed?
How likely is cancer in an asymptomatic endometrial polyp?
What happens if I choose to watch an asymptomatic uterine polyp?
What is the usual procedure to remove an endometrial polyp?
Should an endometrial polyp be removed before fertility treatment?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Monitoring the polyp
Would a repeat transvaginal ultrasound in several months be a reasonable way to watch it?
Polyp size and removal
Would the polyp's size affect whether removal is recommended for me?
Removal and testing
How would a hysteroscopic polypectomy work, and would the polyp tissue be tested?
Related questions
Show more
Get notified when new evidence is published on uterine polyp.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
Endometrial polyps. An evidence-based diagnosis and management guide.
Vitale SG, Haimovich S, Laganà AS, et al.
European journal of obstetrics, gynecology, and reproductive biology 2021; (260()):70-77 doi:10.1016/j.ejogrb.2021.03.017.
PMID: 33756339 - 2
Guideline No. 447: Diagnosis and Management of Endometrial Polyps.
Bougie O, Randle E, Thurston J, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2024; (46(3)):102402 doi:10.1016/j.jogc.2024.102402.
PMID: 38325734 - 3
The risk of malignancy in uterine polyps: A systematic review and meta-analysis.
Uglietti A, Buggio L, Farella M, et al.
European journal of obstetrics, gynecology, and reproductive biology 2019; (237()):48-56 doi:10.1016/j.ejogrb.2019.04.009.
PMID: 31009859 - 4
Expectant management as a primary approach for asymptomatic endometrial polyps: An ambispective cohort study.
Silva AR, Santos M, Coelho A, et al.
European journal of obstetrics, gynecology, and reproductive biology 2026; (319()):114986 doi:10.1016/j.ejogrb.2026.114986.
PMID: 41637906 - 5
Endometrial polyps: Is the prediction of spontaneous regression possible?
Yuksel S, Tuna G, Celik HG, Salman S
Obstetrics & gynecology science 2021; (64(1)):114-121 doi:10.5468/ogs.20242.
PMID: 33321559 - 6
Predictive factors of spontaneously regressed uterine endometrial polyps during the waiting period before hysteroscopic polypectomy.
Okamura A, Yano E, Isono W, et al.
Journal of medical case reports 2021; (15(1)):384 doi:10.1186/s13256-021-02982-4.
PMID: 34332637 - 7
Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis.
Sasaki LMP, Andrade KRC, Figueiredo ACMG, et al.
Journal of minimally invasive gynecology 2018; (25(5)):777-785 doi:10.1016/j.jmig.2018.02.004.
PMID: 29454147 - 8
The clinical importance of polyp size measurement through two-dimensional saline infusion sonohysterography prior to hysteroscopic resection in predicting premalignant and malignant endometrial lesions.
Akış S, Kıran G, Göçmen A
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2022; (157(3)):582-587 doi:10.1002/ijgo.13925.
PMID: 34510415 - 9
Prediction of Premalignant and Malignant Endometrial Polyps by Clinical and Hysteroscopic Features.
Shor S, Pansky M, Maymon R, et al.
Journal of minimally invasive gynecology 2019; (26(7)):1311-1315 doi:10.1016/j.jmig.2018.12.018.
PMID: 30611972 - 10
Clinical significance of endometrial abnormalities: an observational study on 1020 women undergoing hysteroscopic surgery.
Patrizi L, Ticconi C, Borelli B, et al.
BMC women's health 2022; (22(1)):106 doi:10.1186/s12905-022-01682-5.
PMID: 35392892 - 11
Comparing endometrial biopsy results with hysteroscopic pathology in women presenting with abnormal and postmenopausal uterine bleeding.
Ferrando CA, Lintel MK, Bradley LD
Journal of gynecology obstetrics and human reproduction 2023; (52(10)):102685 doi:10.1016/j.jogoh.2023.102685.
PMID: 37871649 - 12
The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea.
Jang S, Hwang SO
European journal of obstetrics, gynecology, and reproductive biology 2024; (295()):118-123 doi:10.1016/j.ejogrb.2024.01.033.
PMID: 38354603 - 13
Risk of malignancy on suspicion of polyps in menopausal women.
Bel S, Billard C, Godet J, et al.
European journal of obstetrics, gynecology, and reproductive biology 2017; (216()):138-142 doi:10.1016/j.ejogrb.2017.07.013.
PMID: 28763739 - 14
Risks of Malignancy among 11,204 Patients with Endometrial Polyp: A Systematic Review and Meta-analysis.
Al-Rayes S, Mohamed M, Suarthana E, et al.
Gynecology and minimally invasive therapy 2025; (14(1)):40-50 doi:10.4103/gmit.GMIT-D-24-00056.
PMID: 40143979 - 15
Diagnostic Assessment of Tamoxifen-Associated Endometrial Pathology: A Narrative Review of Biomarkers, Risk Models, and Translational Gaps.
Hakami MA
Diagnostics (Basel, Switzerland) 2026; (16(20)) doi:10.3390/diagnostics16203388.
PMID: 42938227 - 16
To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps.
Sheng KK, Lyons SD
Climacteric : the journal of the International Menopause Society 2020; (23(4)):336-342 doi:10.1080/13697137.2020.1742107.
PMID: 32496825 - 17
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
Bosteels J, van Wessel S, Weyers S, et al.
The Cochrane database of systematic reviews 2018; (12()):CD009461 doi:10.1002/14651858.CD009461.pub4.
PMID: 30521679 - 18
Hysteroscopic Resection of Endometrial Polyps and Assisted Reproductive Technology Pregnancy Outcomes Compared with No Treatment: A Systematic Review.
Zhang H, He X, Tian W, et al.
Journal of minimally invasive gynecology 2019; (26(4)):618-627 doi:10.1016/j.jmig.2018.10.024.
PMID: 30557636 - 19
Management of endometrial polyps in infertile women: A mini-review.
Jee BC, Jeong HG
Clinical and experimental reproductive medicine 2021; (48(3)):198-202 doi:10.5653/cerm.2020.04119.
PMID: 34352167 - 20
The natural history of endometrial polyps.
Wong M, Crnobrnja B, Liberale V, et al.
Human reproduction (Oxford, England) 2017; (32(2)):340-345 doi:10.1093/humrep/dew307.
PMID: 27994000 - 21
Outpatient Hysteroscopic Polypectomy-A Retrospective Study Comparing Rigid and Semirigid Office Hysteroscopes.
Chiofalo B, Calandra M, Bruno V, et al.
Diagnostics (Basel, Switzerland) 2023; (13(5)) doi:10.3390/diagnostics13050988.
PMID: 36900132 - 22
Effectiveness of Hysteroscopic Techniques for Endometrial Polyp Removal: The Italian Multicenter Trial.
Luerti M, Vitagliano A, Di Spiezio Sardo A, et al.
Journal of minimally invasive gynecology 2019; (26(6)):1169-1176 doi:10.1016/j.jmig.2018.12.002.
PMID: 30528831 - 23
Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions.
Sebbag L, Even M, Fay S, et al.
Frontiers in surgery 2019; (6()):50 doi:10.3389/fsurg.2019.00050.
PMID: 31475154
This page is for informational purposes only and does not replace medical advice. A gynecologist can help you decide whether observation or hysteroscopic removal is appropriate for your specific polyp and risk factors.